PANTHERx® Now Stocking Makena Subcutaneous Auto-Injector

PANTHERx® Specialty Pharmacy is now stocking and dispensing Makena (hydroxyprogesterone caproate injection) subcutaneous auto-injector, a new drug-device combination product.  The new subcutaneous auto-injector offers a convenient, ready-to-use alternative to the intramuscular injection.  Makena is the only FDA approved treatment indicated to reduce the risk of preterm birth in women who are pregnant with one baby and who spontaneously delivered one preterm baby in the past.

For more information about Makena, please visit:

For more information, contact PANTHERx® Specialty Pharmacy at 855-726-8479.

PANTHERx® at sPCMA Business Forum

Join the leaders from PANTHERx® Specialty Pharmacy at the 2018 sPCMA Business Forum, March 5-6, in Orlando, Florida.  The conference brings together leaders in specialty pharmacy, payers, PBMs, pharmaceutical manufacturers, and other stakeholders for collaboration, networking, and education.

Leaders from PANTHERx® will be available for meetings outside of the scheduled agenda sessions.  David Stasiowski, Vice President, Business Development and Managed Markets, can be contacted at to schedule an appointment.

For more information on the sPCMA Business Forum, please visit